Mayssam Nehme

Mayssam Nehme

Auto-generated profile, based on publicly available information

Mayssam Nehme

Affiliations Division of Primary Care Medicine, Geneva University Hospitals, Geneva, Switzerland, Faculty of Medicine, University of Geneva, Geneva, Switzerland

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2021 in Annals of Internal Medicine
Verified
Journal Article
Open access
MNMayssam Nehme
Mayssam Nehme
OBOlivia Braillard
Olivia Braillard
GAGabriel Alcoba
Gabriel Alcoba
SPSigiriya Aebischer Perone
Sigiriya Aebischer Perone
DCDelphine Courvoisier
Delphine Courvoisier
IGIdris Guessous
Idris Guessous

1 September 2021 in Annals of Internal Medicine
Verified
Journal Article
Open access
MNMayssam Nehme
Mayssam Nehme
OBOlivia Braillard
Olivia Braillard
FCFrançois Chappuis
François Chappuis
DCDelphine S Courvoisier
Delphine S Courvoisier
IGIdris Guessous
Idris Guessous
Coronavirus disease 2019 (COVID-19) can lead to long-term health effects. This article systematically characterizes the prevalence and longitudinal evolution of COVID-19 symptoms more than 7 months... Visual Prevalence of Symptoms More Than 7 Months After Symptomatic COVID-19. Coronavirus disease 2019 (COVID-19) can lead to long-term health effects. This article systematically character... Background: With millions of SARS-CoV-2 infections worldwide, increasing numbers of patients are coming forward with long-term clinical effects of the disease lasting several weeks to months. Objec...

25 August 2022 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MNMayssam Nehme
Mayssam Nehme
OBOlivia Braillard
Olivia Braillard
FCFrançois Chappuis
François Chappuis
IGIdris Guessous
Idris Guessous
Post-COVID condition is prevalent in 10–35% of cases in outpatient settings, however a stratification of the duration and severity of symptoms is still lacking, adding to the complexity and heterogeneity of the definition of post-COVID condition and its oucomes. In addition, the potential impacts of a longer duration of disease are not yet clear, along with which risk factors are associated with a chronification of symptoms beyond the initial 12 weeks. In this study, follow-up was conducted at 7 and 15 months after testing at the outpatient SARS-CoV-2 testing center of the Geneva University Hospitals. The chronification of symptoms was defined as the continuous presence of symptoms at each evaluation timepoint (7 and 15 months). Adjusted estimates of healthcare utilization, treatment, functional impairment and quality of life were calculated. Logistic regression models were used to evaluate the associations between the chronification of symptoms and predictors. Overall 1383 participants were included, with a mean age of 44.3 years, standard deviation (SD) 13.4 years, 61.4% were women and 54.5% did not have any comorbidities. Out of SARS-CoV-2 positive participants (n = 767), 37.0% still had symptoms 7 months after their test of which 47.9% had a resolution of symptoms at the second follow-up (15 months after the infection), and 52.1% had persistent symptoms and were considered to have a chronification of their post-COVID condition. Individuals with a chronification of symptoms had an increased utilization of healthcare resources, more recourse to treatment, more functional impairment, and a poorer quality of life. Having several symptoms at testing and difficulty concentrating at 7 months were associated with a chronification of symptoms. COVID-19 patients develop post-COVID condition to varying degrees and duration. Individuals with a chronification of symptoms experience a long-term impact on their health status, functional capacity and quality of life, requiring a special attention, more involved care and early on identification considering the associated predictors.

9 February 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
DYDana Yelin
Dana Yelin
IMIli Margalit
Ili Margalit
MNMayssam Nehme
Mayssam Nehme
Jaume Bordas-MartinezJaume Bordas-Martinez
Jaume Bordas-Martinez
Francesco PistelliFrancesco Pistelli
Francesco Pistelli
OGon behalf of the LongCOV Research Group
on behalf of the LongCOV Research Group
Background: Long COVID has become a burden on healthcare systems worldwide. Research into the etiology and risk factors has been impeded by observing all diverse manifestations as part of a single entity. We aimed to determine patterns of symptoms in convalescing COVID-19 patients. Methods: Symptomatic patients were recruited from four countries. Data were collected regarding demographics, comorbidities, acute disease and persistent symptoms. Factor analysis was performed to elucidate symptom patterns. Associations of the patterns with patients’ characteristics, features of acute disease and effect on daily life were sought. Results: We included 1027 symptomatic post-COVID individuals in the analysis. The majority of participants were graded as having a non-severe acute COVID-19 (N = 763, 74.3%). We identified six patterns of symptoms: cognitive, pain-syndrome, pulmonary, cardiac, anosmia-dysgeusia and headache. The cognitive pattern was the major symptoms pattern, explaining 26.2% of the variance; the other patterns each explained 6.5–9.5% of the variance. The cognitive pattern was higher in patients who were outpatients during the acute disease. The pain-syndrome pattern was associated with acute disease severity, higher in women and increased with age. The pulmonary pattern was associated with prior lung disease and severe acute disease. Only two of the patterns (cognitive and cardiac) were associated with failure to return to pre-COVID occupational and physical activity status. Conclusion: Long COVID diverse symptoms can be grouped into six unique patterns. Using these patterns in future research may improve our understanding of pathophysiology and risk factors of persistent COVID, provide homogenous terminology for clinical research, and direct therapeutic interventions.

22 February 2022 in Journal of General Internal Medicine
Verified
Journal Article
Open access
PDF file
MNMayssam Nehme
Mayssam Nehme
OBOlivia Braillard
Olivia Braillard
JSJulien Salamun
Julien Salamun
FJFrédérique Jacquerioz
Frédérique Jacquerioz
DCDelphine S. Courvoisier
Delphine S. Courvoisier
IGIdris Guessous
Idris Guessous

15 December 2022 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
MNMayssam Nehme
Mayssam Nehme
PVPauline Vetter
Pauline Vetter
FCFrançois Chappuis
François Chappuis
LKLaurent Kaiser
Laurent Kaiser
IGIdris Guessous
Idris Guessous
Background: Post-coronovirus disease (COVID) symptoms can persist several months after severe acute respiratory syndrome coronavirus 2 infection. Little is known, however, about the prevalence of post-COVID condition following infections from Omicron variants and how this varies according to vaccination status. This study evaluates the prevalence of symptoms and functional impairment 12 weeks after an infection by Omicron variants (BA.1 and BA.2) compared with negative controls tested during the same period. Methods: Outpatient individuals who tested positive or negative for COVID-19 infection between December 2021 and February 2022 at the Geneva University Hospitals were followed 12 weeks after their test date. Results: Overall, 11.7% of Omicron cases had symptoms 12 weeks after the infection compared with 10.4% of individuals who tested negative during the same period (P < .001), and symptoms were much less common in vaccinated versus nonvaccinated individuals with Omicron infection (9.7% vs 18.1%; P < .001). There were no significant differences in functional impairment at 12 weeks between Omicron cases and negative controls, even after adjusting for multiple potential confounders. Conclusions: The differential prevalence of post-COVID symptoms and functional impairment attributed to Omicron BA.1 and BA.2 infection is low when compared with negative controls. Vaccination is associated with lower prevalence of post-COVID symptoms.